Cargando…
Avanafil for male erectile dysfunction: a systematic review and meta-analysis
Avanafil, a potent new selective phosphodiesterase type 5 (PDE5) inhibitor, has been developed for the treatment of erectile dysfunction (ED). We carried out a systematic review and meta-analysis to assess the efficacy and safety of this drug for the treatment of ED. A literature review was performe...
Autores principales: | Cui, Yuan-Shan, Li, Nan, Zong, Huan-Tao, Yan, Hui-Lei, Zhang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023381/ https://www.ncbi.nlm.nih.gov/pubmed/24589460 http://dx.doi.org/10.4103/1008-682X.123670 |
Ejemplares similares
-
Avanafil for erectile dysfunction
Publicado: (2019) -
Avanafil for treatment of erectile dysfunction: review of its potential
por: Burke, Ryan M, et al.
Publicado: (2012) -
Avanafil for the Treatment of men With Erectile Dysfunction: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Li, Jinze, et al.
Publicado: (2019) -
Future prospects in the treatment of erectile dysfunction: focus on avanafil
por: Alwaal, Amjad, et al.
Publicado: (2011) -
The Efficacy and Safety of Avanafil During a Treatment of Male Erectile Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Warli, Syah Mirsya, et al.
Publicado: (2023)